# Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies.

> **NCT02323516** · PHASE2 · WITHDRAWN · sponsor: **Centre Francois Baclesse**

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Acetylsalicylic acid + loperamide
- **DRUG:** diosmectite + loperamide

## Key facts

- **NCT ID:** NCT02323516
- **Lead sponsor:** Centre Francois Baclesse
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-12
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-12-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02323516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02323516, "Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02323516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*